Noted: At the University of Wisconsin, a CRISPR antibiotic is being developed to selectively target super-resistant bugs. In the UK, researchers used CRISR gene editing to eliminate malaria in new mosquito strains. And last year Chinese scientists corrected lethal mutations in 3 human embryos.
Office of Strategic Communication